Sectors

SILO
Silo Pharma, Inc.
2.48
2 x 1.83
2 x 3.21
bid
ask
-
0.03
1.25%
2 @ 06:04 PM
2.47 -0.01 (0.40%)
Ytd-51.37%
1y-73.67%
2.47
day range
2.55
2.43
52 week range
15.15
Open2.48Prev Close2.51Low2.47High2.55Mkt Cap4.35M
Vol22.63KAvg Vol197.24KEPS-3.74P/EN/AForward P/E-1.26
Beta1.36Short Ratio0.98Inst. Own2.46%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1550-d Avg4.57200-d Avg5.551yr Est10.00
Income Statement
Operating Expenses928.95K
Research and Development Expense298.42K
Selling, General and Administrative Expense318.69K
Operating Income-928.95K
Interest Expense2.87K
Net Income-832.83K
Net Income Common Stock-832.83K
Net Income Common Stock (USD)-832.83K
Consolidated Income-832.83K
Earnings per Basic Share-0.76
Earnings per Basic Share (USD)-0.76
Earnings per Diluted Share-0.76
Earning Before Interest & Taxes (EBIT)-829.96K
Earning Before Interest & Taxes (USD)-829.96K
Weighted Average Shares1.10M
Weighted Average Shares Diluted1.10M
Balance Sheet
Cash and Equivalents3.28M
Cash and Equivalents (USD)3.28M
Investments2.16M
Investments Current2.16M
Current Assets5.71M
Total Assets5.95M
Current Liabilities1.07M
Total Liabilities1.07M
Accumulated Retained Earnings (Deficit)-21.97M
Accumulated Other Comprehensive Income6.83K
Shareholders Equity4.89M
Shareholders Equity (USD)4.89M
Assets Non-Current238.50K
Goodwill and Intangible Assets211.50K
Trade and Non-Trade Payables362.18K
Cash Flow
Depreciation, Amortization & Accretion2.94K
Net Cash Flow / Change in Cash & Cash Equivalents-625.42K
Net Cash Flow from Investing183.44K
Net Cash Flow - Investment Acquisitions and Disposals183.44K
Net Cash Flow from Operations-781.86K
Share Based Compensation39.17K